Related Experiment Videos
Subcutaneous blood flow in early male pattern baldness
1Department of Dermatology, Gentofte Hospital, University of Copenhagen, Denmark.
The Journal of Investigative Dermatology
|May 1, 1989
Summary
Subcutaneous blood flow (SBF) in the scalp is significantly reduced in men with early male pattern baldness. This finding suggests that decreased blood supply to hair follicles may contribute to hair loss.
Area of Science:
- Dermatology
- Medical Physiology
- Hair Biology
Background:
- Male pattern baldness is a common condition with multifactorial causes.
- The role of vascular factors in the pathogenesis of androgenetic alopecia is not fully understood.
- Previous studies have not extensively investigated scalp blood flow in early-stage male pattern baldness.
Purpose of the Study:
- To measure and compare subcutaneous blood flow (SBF) in the scalp of individuals with early male pattern baldness and age-matched controls.
- To investigate the potential link between reduced SBF and the development of male pattern baldness.
Main Methods:
- Subcutaneous blood flow (SBF) was assessed using the 133Xe washout technique.
- Measurements were taken in the scalp of 14 patients diagnosed with early male pattern baldness.
- A control group of 14 age-matched healthy men with normal hair density was included for comparison.
Main Results:
- Scalp SBF in normal individuals was approximately 10 times higher than previously reported values in other body regions.
- Patients with early male pattern baldness exhibited significantly lower SBF compared to controls (13.7 +/- 9.6 ml/100 g/min vs 35.7 +/- 10.5 ml/100 g/min).
- The observed reduction in SBF for the baldness group was statistically significant (p < 0.001).
Conclusions:
- A significant reduction in scalp subcutaneous blood flow is associated with early male pattern baldness.
- Diminished nutritive blood flow to the hair follicles is a potential contributing factor in the pathogenesis of male pattern baldness.
- Further research into vascular mechanisms is warranted for understanding and treating androgenetic alopecia.